Certified by Founder Lodge
Encellin
United States - Mountain View
START UP
1 Disclosed Funding Rounds $9,900,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Encellin is focused on advancing next generation therapies, starting with endocrine disorders.
We are developing a minimally invasive implant delivering therapeutics where needed. Our tech
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 14 ,2023 | Unknown | $9,900,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Turion Space | $75,000,000 | (Apr 15, 2026)
nEye.ai | $80,000,000 | (Apr 15, 2026)
Prefix Maintenance | $7,500,000 | (Apr 15, 2026)
Synera | $40,000,000 | (Apr 15, 2026)
Sygaldry Technologies | $105,000,000 | (Apr 15, 2026)
